Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
ipo
5
×
life sciences
national blog main
national top stories
new york blog main
san diego blog main
5
×
san diego top stories
san francisco blog main
vc
5
×
venture capital
5
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
cancer
celgene
drug development
fda
gene editing
novartis
biomarin pharmaceutical
car-t
commissioner
What
bio
roundup
ipo
new
activity
advance
allogene
approvals
becker
billions
biogen
biology
biopharma
cancer
car
celgene
clamped
colleagues
company
covid
crispr
cytokine
delays
developing
diversity
dollars
drugs
eaton
economic
enhanced
exome
fast
fda
files
gene
government
health
healthcare
hot
hundreds
Language
unset
Current search:
ipo
×
vc
×
" venture capital "
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More